Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement
Dyslipidemia due to genetic and multifactorial dyslipidemia has a predisposition to early-onset atherosclerotic cardiovascular disease (ASCVD), and consensus and guidelines regarding lipid lowering in adults are well established, but the benefits of lipid screening and treatment in childhood and ado...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese General Practice Publishing House Co., Ltd
2024-05-01
|
| Series: | Zhongguo quanke yixue |
| Subjects: | |
| Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/1709085519905-1296075477.pdf |
| _version_ | 1797216477066035200 |
|---|---|
| author | LIU Wenjun, YAO Mi, JING Guanning, YAN Cunling, YAN Hui |
| author_facet | LIU Wenjun, YAO Mi, JING Guanning, YAN Cunling, YAN Hui |
| author_sort | LIU Wenjun, YAO Mi, JING Guanning, YAN Cunling, YAN Hui |
| collection | DOAJ |
| description | Dyslipidemia due to genetic and multifactorial dyslipidemia has a predisposition to early-onset atherosclerotic cardiovascular disease (ASCVD), and consensus and guidelines regarding lipid lowering in adults are well established, but the benefits of lipid screening and treatment in childhood and adolescence for this population are not well established. The United States Preventive Medicine Task Force (USPSTF) issued the Recommendation Statement: Screening for Dyslipidemia in Children and Adolescents based on a systematic review of evidence with meta-analysis conducted in a large number of randomized controlled trials, large cohort studies in European and American countries, with the aim of assessing evidences whether initiation of lipid screening and early initiation of treatment in childhood and adolescence has long-term benefits for this population. This article provides a detailed interpretation of the guideline, which aims to provide reference to clinical healthcare workers to improve the understanding of dyslipidaemia in children and to decide whether to screen them with a view to reducing the incidence of cardiovascular disease in adulthood. |
| first_indexed | 2024-04-24T11:46:35Z |
| format | Article |
| id | doaj.art-115e92f15cee4741a46ff0e83b6667be |
| institution | Directory Open Access Journal |
| issn | 1007-9572 |
| language | zho |
| last_indexed | 2024-04-24T11:46:35Z |
| publishDate | 2024-05-01 |
| publisher | Chinese General Practice Publishing House Co., Ltd |
| record_format | Article |
| series | Zhongguo quanke yixue |
| spelling | doaj.art-115e92f15cee4741a46ff0e83b6667be2024-04-09T09:36:45ZzhoChinese General Practice Publishing House Co., LtdZhongguo quanke yixue1007-95722024-05-0127151796180110.12114/j.issn.1007-9572.2024.0002Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation StatementLIU Wenjun, YAO Mi, JING Guanning, YAN Cunling, YAN Hui01. Department of Pediastrics, Peking University First Hospital, Beijing 100034, China;2. Department of General Practice, Peking University First Hospital, Beijing 100034, China;3. Department of Clinical Laboratory, Peking University First Hospital, Beijing 100034, ChinaDyslipidemia due to genetic and multifactorial dyslipidemia has a predisposition to early-onset atherosclerotic cardiovascular disease (ASCVD), and consensus and guidelines regarding lipid lowering in adults are well established, but the benefits of lipid screening and treatment in childhood and adolescence for this population are not well established. The United States Preventive Medicine Task Force (USPSTF) issued the Recommendation Statement: Screening for Dyslipidemia in Children and Adolescents based on a systematic review of evidence with meta-analysis conducted in a large number of randomized controlled trials, large cohort studies in European and American countries, with the aim of assessing evidences whether initiation of lipid screening and early initiation of treatment in childhood and adolescence has long-term benefits for this population. This article provides a detailed interpretation of the guideline, which aims to provide reference to clinical healthcare workers to improve the understanding of dyslipidaemia in children and to decide whether to screen them with a view to reducing the incidence of cardiovascular disease in adulthood.https://www.chinagp.net/fileup/1007-9572/PDF/1709085519905-1296075477.pdfdyslipidemias|child|adolescent|screening|united states preventive medicine task force |
| spellingShingle | LIU Wenjun, YAO Mi, JING Guanning, YAN Cunling, YAN Hui Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement Zhongguo quanke yixue dyslipidemias|child|adolescent|screening|united states preventive medicine task force |
| title | Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement |
| title_full | Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement |
| title_fullStr | Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement |
| title_full_unstemmed | Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement |
| title_short | Interpretation of Screening for Lipid Disorders in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement |
| title_sort | interpretation of screening for lipid disorders in children and adolescents u s preventive services task force recommendation statement |
| topic | dyslipidemias|child|adolescent|screening|united states preventive medicine task force |
| url | https://www.chinagp.net/fileup/1007-9572/PDF/1709085519905-1296075477.pdf |
| work_keys_str_mv | AT liuwenjunyaomijingguanningyancunlingyanhui interpretationofscreeningforlipiddisordersinchildrenandadolescentsuspreventiveservicestaskforcerecommendationstatement |